(WEHT) – The Illinois State Senate passed a bill to cap insulin prices in the state.
Opponents of the bill believe the price cap will stop innovation for the drug.
Advocates think it could be the start of a much bigger movement.
The bill limits out-of-pocket expenses for people on state-regulated health insurance plans.
Those on federally regulated plans would still pay the market price.
(This story was originally published on October 29, 2019)